EVOLUS INC - ANNOUNCES POSITIVE RESULTS FOR EVOLYSSE SCULPT STUDY
EVOLUS: EVOLYSSE SCULPT MET PRIMARY ENDPOINT OF NON-INFERIORITY & DEMONSTRATED STATISTICAL SUPERIORITY TO RESTYLANE-LYFT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.